Ledger.Open graph →
SEC Form D · filed January 3, 2018

Aura Biosciences, Inc

Offering
$42.3M
Sold
$32.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Alan E. Walts, Ph.D · Cambridge, MADirectorLewis E. Geffen · Cambridge, MAExecElisabet De Los Pinos, Ph.D · Cambridge, MAExec · DirectorMichael E. Wyzga · Cambridge, MAExecArt E. Pappas · Cambridge, MADirectorCasper E. Breum · Cambridge, MADirectorMark E. Chin · Cambridge, MADirectorDale E. Pfost, Ph.D · Cambridge, MADirectorJoel E. Jean-Mairet, Ph.D · Cambridge, MADirectorDeepak Sindwani · Boston, MAExecPeter B. Franz · PONTE VEDRA BEACH, FLDirectorPhillip Chapple · Hamilton, BermudaExecHarold D. Keller · Columbus, OHDirectorJohn P. Lee · Columbus, OHDirectorDenise A. Olsen · CHICAGO, ILExec · DirectorMichael Hand · PONTE VEDRA BEACH, FLDirectorRichard L. Mcquady · Columbus, OHDirectorEric M. Siegal · CHICAGO, ILExec · DirectorDennis S. Guest · Columbus, OHDirectorThomas T. Loos · Columbus, OHDirectorDaniel M. Slane · COLUMBUS, OHDirectorSusan E. Weaver · Columbus, OHDirectorMichael A. Bruun · NEW YORK, NYExecAnthony M. Farwell · Seattle, WAExecJack T. Benson, Do · Columbus, OHDirectorJoseph T. Worischeck, Md · Columbus, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗